Angene Chemical
Draw
|
Currency :
Home Products

AG007LC5

265312-55-8 | 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione

Chemical structure of 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione, CAS 265312-55-8
AG007LC5
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 265312-55-8
Catalog Number AG007LC5(AGN-PC-0JRRJP)
Chemical Name 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione
IUPAC Name 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione
InChI InChI=1S/C15H12N2O2S/c1-8-3-5-10(6-4-8)17-11-7-12(18)15-13(14(11)19)16-9(2)20-15/h3-7,17H,1-2H3
InChI Key HFPLHASLIOXVGS-UHFFFAOYSA-N
MDL Number MFCD09971103
Molecular Formula C15H12N2O2S
Molecular Weight 284.3330
SMILES CC=1SC2=C(N1)C(C(=CC2=O)NC2=CC=C(C=C2)C)=O
Synonyms
Ryuvidine, Cdk4 Inhibitor III, 265312-55-8, 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione, CHEMBL290904, 5-(N-(4-Methylphenyl)amino)-2-methyl-4,7-dioxobenzothiazole, 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione, AC1Q6BBC, AC1LA59T, 2-Methyl-5-p-tolylamino-benzothiazole-4,7-dione, GTPL5952, SCHEMBL2169284, CHEBI:92119, CTK4F8075, AOB6479, HMS3229E08, HMS3269F11, HMS3677J19, ZINC5930916, 2-METHYL-5-[(4-METHYLPHENYL)AMINO]-4,7-BENZOTHIAZOLEDIONE, BDBM50086655, AKOS024457195, CCG-206830, NCGC00167794-01, AS-16953, RT-011960, B7128, J-016463, 2-methyl-5-(p-tolylamino)benzo[d]thiazole-4,7-dione, BRD-K06426971-001-01-9, 2-Methyl-5-(4-methylphenylamino)-4,7-dihydrobenzothiazole-4,7-dione, 2-methyl-5-[(4-methylphenyl)amino]-4,7-dihydro-1,3-benzothiazole-4,7-dione, D07HPE, 4,7-Dioxobenzothiazole analog, AIDS097146, AR-1E3725, CID481747, 26719-47-1,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited